Ab Science Sa Stock Analysis
| ABSCF Stock | USD 1.45 0.00 0.00% |
AB Science SA has over 6.69 Million in debt which may indicate that it relies heavily on debt financing. AB Science's financial risk is the risk to AB Science stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
AB Science's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. AB Science's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps ABSCF Pink Sheet's retail investors understand whether an upcoming fall or rise in the market will negatively affect AB Science's stakeholders.
For many companies, including AB Science, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for AB Science SA, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, AB Science's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that AB Science's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which AB Science is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of AB Science to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, AB Science is said to be less leveraged. If creditors hold a majority of AB Science's assets, the Company is said to be highly leveraged.
AB Science SA is undervalued with Real Value of 1.65 and Hype Value of 1.45. The main objective of AB Science pink sheet analysis is to determine its intrinsic value, which is an estimate of what AB Science SA is worth, separate from its market price. There are two main types of AB Science's stock analysis: fundamental analysis and technical analysis.
The AB Science pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and AB Science's ongoing operational relationships across important fundamental and technical indicators.
ABSCF |
ABSCF Pink Sheet Analysis Notes
About 41.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.32. AB Science SA had not issued any dividends in recent years. The entity had 1000:1 split on the 31st of December 2009. AB Science S.A., a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France. Ab Science operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 100 people.The quote for AB Science SA is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on AB Science SA please contact the company at 33 1 47 20 00 14 or go to https://www.ab-science.com.AB Science SA Investment Alerts
| AB Science SA may become a speculative penny stock | |
| AB Science SA has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| AB Science SA has accumulated 6.69 M in total debt with debt to equity ratio (D/E) of 102.9, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. AB Science SA has a current ratio of 0.87, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist AB Science until it has trouble settling it off, either with new capital or with free cash flow. So, AB Science's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like AB Science SA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for ABSCF to invest in growth at high rates of return. When we think about AB Science's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 1.61 M. Net Loss for the year was (14.46 M) with profit before overhead, payroll, taxes, and interest of 1.5 M. | |
| AB Science SA has accumulated about 7.64 M in cash with (17.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.16. | |
| Roughly 41.0% of AB Science shares are held by company insiders |
ABSCF Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 421.75 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AB Science's market, we take the total number of its shares issued and multiply it by AB Science's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 11th of February 2026, AB Science owns the Variance of 3.05, information ratio of 0.0768, and Market Risk Adjusted Performance of 2.08. AB Science SA technical analysis gives you the methodology to make use of past data patterns to determine a pattern that approximates the direction of the entity's future prices. Please confirm AB Science SA coefficient of variation, as well as the relationship between the total risk alpha and skewness to decide if AB Science SA is priced fairly, providing market reflects its prevailing price of 1.45 per share. Please also double-check AB Science information ratio, which is currently at 0.0768 to validate the company can sustain itself sooner or later.AB Science SA Price Movement Analysis
Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. The Weighted Moving Average calculates a weight for each value in AB Science price series with the more recent values given greater weights.
AB Science Predictive Daily Indicators
AB Science intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of AB Science pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
AB Science Forecast Models
AB Science's time-series forecasting models are one of many AB Science's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary AB Science's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.AB Science SA Debt to Cash Allocation
Many companies such as AB Science, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
AB Science SA has accumulated 6.69 M in total debt with debt to equity ratio (D/E) of 102.9, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. AB Science SA has a current ratio of 0.87, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist AB Science until it has trouble settling it off, either with new capital or with free cash flow. So, AB Science's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like AB Science SA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for ABSCF to invest in growth at high rates of return. When we think about AB Science's use of debt, we should always consider it together with cash and equity.AB Science Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the AB Science's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of AB Science, which in turn will lower the firm's financial flexibility.About ABSCF Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how AB Science prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling ABSCF shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as AB Science. By using and applying ABSCF Pink Sheet analysis, traders can create a robust methodology for identifying ABSCF entry and exit points for their positions.
AB Science S.A., a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France. Ab Science operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 100 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding AB Science to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Equity Forecasting Now
Equity ForecastingUse basic forecasting models to generate price predictions and determine price momentum |
| All Next | Launch Module |
Complementary Tools for ABSCF Pink Sheet analysis
When running AB Science's price analysis, check to measure AB Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AB Science is operating at the current time. Most of AB Science's value examination focuses on studying past and present price action to predict the probability of AB Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AB Science's price. Additionally, you may evaluate how the addition of AB Science to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |